VF
ACHL

Virtu Financial’s Achilles Therapeutics ACHL Stock Holding History

Virtu Financial’s Portfolio ACHL Stock Details ACHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22,813
Closed -$19K – 2001
2024
Q2 		$19K Buy
22,813
+1,866
+9% +$1.64K ﹤0.01% 1041
2024
Q1 		$26K Sell
20,947
-18,646
-47% -$20.1K ﹤0.01% 1133
2023
Q4 		$35K Buy
+39,593
New +$33.9K ﹤0.01% 1234
2023
Q3 		– Sell
-16,790
Closed -$16K – 2024
2023
Q2 		$16K Buy
+16,790
New +$15.9K ﹤0.01% 1300
2023
Q1 		– Sell
-31,003
Closed -$28K – 2210
2022
Q4 		$28K Buy
+31,003
New +$52.2K ﹤0.01% 1199

Other funds holding ACHL

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Virtu Financial's ACHL Position: Q3 2024 in Review

Virtu Financial sold out of Achilles Therapeutics (ACHL) in Q3 2024, closing a stake of 22,813 shares — an estimated $19K sold.

Virtu Financial first reported a position in ACHL in Q4 2022 and held it in 5 quarters. The position peaked at $35K in Q4 2023. 22 funds tracked by Wall St. Rank hold ACHL as of Q3 2024.

  • Virtu Financial reported no remaining Achilles Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 22,813 Achilles Therapeutics shares in Q3 2024, an estimated $19K.
  • Virtu Financial first reported a position in Achilles Therapeutics in Q4 2022 and held it in 5 quarters.
  • Virtu Financial's Achilles Therapeutics position peaked at $35K in Q4 2023.
  • 22 funds tracked by Wall St. Rank held Achilles Therapeutics as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.